rs121908242

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2

The NM_001127222.2(CACNA1A):​c.2687C>T​(p.Pro896Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000903 in 1,439,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P896R) has been classified as Benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000090 ( 0 hom. )

Consequence

CACNA1A
NM_001127222.2 missense

Scores

2
3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.73

Publications

6 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.19471204).
BP6
Variant 19-13298946-G-A is Benign according to our data. Variant chr19-13298946-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 943049.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAdExome4 at 13 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.2687C>T p.Pro896Leu missense_variant Exon 19 of 47 ENST00000360228.11 NP_001120694.1
CACNA1ANM_001127221.2 linkc.2690C>T p.Pro897Leu missense_variant Exon 19 of 47 ENST00000638009.2 NP_001120693.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.2687C>T p.Pro896Leu missense_variant Exon 19 of 47 1 NM_001127222.2 ENSP00000353362.5
CACNA1AENST00000638009.2 linkc.2690C>T p.Pro897Leu missense_variant Exon 19 of 47 1 NM_001127221.2 ENSP00000489913.1
CACNA1AENST00000638029.1 linkc.2699C>T p.Pro900Leu missense_variant Exon 19 of 48 5 ENSP00000489829.1
CACNA1AENST00000573710.7 linkc.2693C>T p.Pro898Leu missense_variant Exon 19 of 47 5 ENSP00000460092.3
CACNA1AENST00000635727.1 linkc.2690C>T p.Pro897Leu missense_variant Exon 19 of 47 5 ENSP00000490001.1
CACNA1AENST00000637769.1 linkc.2690C>T p.Pro897Leu missense_variant Exon 19 of 47 1 ENSP00000489778.1
CACNA1AENST00000636012.1 linkc.2690C>T p.Pro897Leu missense_variant Exon 19 of 46 5 ENSP00000490223.1
CACNA1AENST00000637736.1 linkc.2549C>T p.Pro850Leu missense_variant Exon 18 of 46 5 ENSP00000489861.1
CACNA1AENST00000636389.1 linkc.2690C>T p.Pro897Leu missense_variant Exon 19 of 47 5 ENSP00000489992.1
CACNA1AENST00000637432.1 linkc.2699C>T p.Pro900Leu missense_variant Exon 19 of 48 5 ENSP00000490617.1
CACNA1AENST00000636549.1 linkc.2690C>T p.Pro897Leu missense_variant Exon 19 of 48 5 ENSP00000490578.1
CACNA1AENST00000637927.1 linkc.2693C>T p.Pro898Leu missense_variant Exon 19 of 47 5 ENSP00000489715.1
CACNA1AENST00000635895.1 linkc.2690C>T p.Pro897Leu missense_variant Exon 19 of 47 5 ENSP00000490323.1
CACNA1AENST00000637276.1 linkc.2690C>T p.Pro897Leu missense_variant Exon 19 of 46 5 ENSP00000489777.1
CACNA1AENST00000636768.2 linkn.2690C>T non_coding_transcript_exon_variant Exon 19 of 45 5 ENSP00000490190.2
CACNA1AENST00000713789.1 linkn.2687C>T non_coding_transcript_exon_variant Exon 19 of 47 ENSP00000519091.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000564
AC:
12
AN:
212834
AF XY:
0.0000169
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000364
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000903
AC:
13
AN:
1439062
Hom.:
0
Cov.:
32
AF XY:
0.00000419
AC XY:
3
AN XY:
715762
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33270
American (AMR)
AF:
0.000297
AC:
13
AN:
43812
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25918
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39316
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85046
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37990
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5594
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1108264
Other (OTH)
AF:
0.00
AC:
0
AN:
59852
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.0000682
AC:
8

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 13, 2023
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Nov 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.21
CADD
Uncertain
23
DANN
Benign
0.79
DEOGEN2
Benign
0.030
.;.;T;.;.;.;.;.;.;T;.;.;.;T;.
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.70
D
LIST_S2
Uncertain
0.91
D;D;D;D;D;D;D;D;.;D;D;D;D;D;D
M_CAP
Pathogenic
0.98
D
MetaRNN
Benign
0.19
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.029
T
MutationAssessor
Benign
1.1
.;.;.;.;L;.;.;.;.;.;.;.;L;.;.
PhyloP100
2.7
PrimateAI
Pathogenic
0.80
D
PROVEAN
Benign
-1.4
.;N;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.25
Sift
Benign
0.12
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Uncertain
0.046
D;D;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.21
MutPred
0.15
.;.;Gain of catalytic residue at P897 (P = 0.1351);Gain of catalytic residue at P897 (P = 0.1351);Gain of catalytic residue at P897 (P = 0.1351);.;Gain of catalytic residue at P897 (P = 0.1351);.;.;Gain of catalytic residue at P897 (P = 0.1351);Gain of catalytic residue at P897 (P = 0.1351);.;Gain of catalytic residue at P897 (P = 0.1351);.;Gain of catalytic residue at P897 (P = 0.1351);
MVP
0.84
MPC
1.1
ClinPred
0.041
T
GERP RS
3.1
Varity_R
0.082
gMVP
0.65
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121908242; hg19: chr19-13409760; API